<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01788800</url>
  </required_header>
  <id_info>
    <org_study_id>221012</org_study_id>
    <nct_id>NCT01788800</nct_id>
  </id_info>
  <brief_title>Physical Activity and Cognitive Behavioural Therapy in Panic Disorder</brief_title>
  <official_title>The Influence of Physical Activity on the Effect of Cognitive Behavioural Therapy, Neurobiological Parameters and Information Processing in Patients With Panic Disorder With/Without Agoraphobia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Federal Ministry of Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Physical activity (treadmill) supports the effect of cognitive behavioural therapy in
      patients with panic disorder with/without agoraphobia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergo cognitive behavioural therapy consisting of 8 group sessions within 1 month.
      All patients additionally complete a training of physical activity, which starts
      simultaneously to therapy and runs for 8 weeks (3 times/week, 30 minutes each). Half of the
      patients complete training on a treadmill while the other half completes a training programme
      of low intensity physical activity without cardiovascular activation.

      Flanking EEG (electroencephalogram) recordings shall help clarify biological processes
      underlying the therapeutical process.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hamilton Rating Scale for Anxiety (CIPS 1995)</measure>
    <time_frame>up to 28 weeks (follow up)</time_frame>
    <description>Global interviewer rated measure for anxiety and severity indicator of an anxiety disorder</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Panic and Agoraphobia Scale (Bandelow et al. 1995)</measure>
    <time_frame>Baseline, 4 weeks, 8 weeks and 28 weeks (follow up)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Anxiety Inventory (CIPS 1995)</measure>
    <time_frame>Baseline, 4 weeks, 8 weeks and 28 weeks (follow up)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Index (CIPS 1995)</measure>
    <time_frame>Baseline, 4 weeks, 8 weeks and 28 weeks (follow up)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory (CIPS 1995)</measure>
    <time_frame>Baseline, 4 weeks, 8 weeks and 28 weeks (follow up)</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>EEG and endocrinology</measure>
    <time_frame>Baseline, 4 weeks, 8 weeks and 28 weeks (follow up)</time_frame>
    <description>EEG (Mismatch Negativity, Loudness dependency, P50/P300) and diurnal profile of Cortisol and alpha-Amylase</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">46</enrollment>
  <condition>Panic Disorder</condition>
  <arm_group>
    <arm_group_label>Exercise training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cognitive Behavioural Therapy (CBT)
+ Exercise training 3 times/week, 30 minutes on a treadmill, 70% maximal oxygen uptake (VO2max), 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Movements</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cognitive Behavioural Therapy (CBT)
+ Low intensity physical activity without cardiovascular activation, 3 times/week, 30 minutes, 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioural Therapy (CBT)</intervention_name>
    <description>9 sessions of CBT including psychoeducation and interoceptive exposure</description>
    <arm_group_label>Exercise training</arm_group_label>
    <arm_group_label>Movements</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject familiarized with experimental procedure and had given written informed
             consent

          2. Diagnosis of panic disorder with or without agoraphobia according to Diagnostic and
             Statistical Manual of Mental Disorders (DSM-IV)

          3. Sufficiently able to communicate with investigator, answer questions and fill in
             questionnaires

          4. Reachability of patient for treatment and follow-up

        Exclusion Criteria:

          1. Other psychiatric illnesses like schizophrenia, substance abuse or severe depressive
             episode

          2. Acute suicidal tendency

          3. Epilepsy or other illness of the central nervous system (e.g. brain tumor,
             encephalitis)

          4. Existence of contraindication against physical exercise

          5. Pregnancy or breastfeeding

          6. Changes of psychopharmacological treatment within the last 4 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Ströhle, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Psychiatry and Psychotherapy, CCM, Charité - Universitätsmedizin Berlin</affiliation>
  </overall_official>
  <link>
    <url>http://www.angstambulanz-charite.de</url>
    <description>Related Info</description>
  </link>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2013</study_first_submitted>
  <study_first_submitted_qc>February 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2013</study_first_posted>
  <last_update_submitted>May 15, 2013</last_update_submitted>
  <last_update_submitted_qc>May 15, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Andreas Ströhle</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>Panic disorder</keyword>
  <keyword>Physical activity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Panic Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

